Long non-coding RNA (lncRNA) has been verified to participate in the tumour regulation, including oral squamous cell carcinoma (OSCC). Nevertheless, the role of lncRNA SNHG20 on OSCC still remains elusive. Here, we investigate the phys- 
| INTRODUCTION
Oral squamous cell carcinoma (OSCC) is an epithelial neoplasm, acting as one of the most aggressive head and neck cancers in human. 1, 2 At histopathological level, OSCC is characterized squamous differentiation, nuclear pleomorphisms, invasive growth and metastasis. 3 Numerous pathogenic factors accelerate the tumorigenesis of OSCC, including smoking, alcohol abuse, human papillomavirus infection. 4 The overall 5-year survival rate of OSCC patients is still pessimistic. Therefore, it is eagerly to develop effective therapeutic targets for the clinical treatment.
Long non-coding RNAs (lncRNAs) are a type of non-coding RNAs (ncRNAs) of 200 nucleotides, playing a vital role in carcinogenesis. 5 Increasing evidences have revealed that lncRNAs participate in the proliferation, metastasis, apoptosis, angiogenesis and drug resistance. 6, 7 For example, lncRNA LINC00668 is up-regulated in OSCC tissues and cells, which is negatively correlated with miR-297 expression in OSCC tissues, promoting OSCC activity through VEGFA signalling. 8 Moreover, lncRNAs might serve as a biomarker in cancer.
For instance, linc-RoR is found to be overexpressed in undifferentiated tumours and presents closely association with OSCCs tumour recurrence and poor prognosis. 9 In present research, our team investigate the role of lncRNA SNHG20 on the OSCC tumorigenesis. The overexpression of SNHG20 accelerates the oncogenesis of OSCC through competing endogenous RNA (ceRNA) regulation. Our results conclude that SNHG20/miR-197/LIN28 axis promotes the tumorigenesis and stemness of OSCC, suggesting the vital role of SNHG20 in OSCC. si-SNHG20-1, 5′-GAAUCGAUAGGUCGAGGGGTT-3′, si-SNHG20-2, 5′-GACAGGCCAUUAGGCCACGCCTT-3′, si-SNHG20-3, 5′-GAAUUA GGAAGCAUUAGGGGTT-3′. Each expression level as the threshold cycle (Ct) was calculated with the 2 −ΔΔCt method and every data was performed in triplicate.
| MATERIALS AND METHODS

| Patients and tissue specimens
| Sphere-formation assay
Sphere-formation assay was performed as previously described. | 681 mL penicillin/streptomycin. The number of spheroids was counted under a stereomicroscope (Olympus, Tokyo, Japan).
| Cell counting kit-8 assay
The proliferation ability of OSCC cells was measured using cell 
| Western blot analysis
The total proteins were extracted from cells using radioimmunoprecipitation assay lysis buffer (Pierce, Rockford, IL, USA). The cell lysates were prepared and equivalent amount of protein was separated by SDS-PAGE for 2 hours. Then, the protein was transfected to polyvinylidene fluoride membranes for 2 hours. After being incubated with primary antibodies at 4°C overnight, the membranes were washed using 1% TBST for 30 minutes. All primary antibodies were provided by Cell Signaling Technology, Inc., Danvers, MA, USA
(1:1000 dilution), including targeting LIN28, Nanog, SOX2, Oct4 and GAPDH. Then, they were incubated with secondary antibodies 
| Statistical analysis
Data were presented as mean ± SD. All results were analysed with GraphPad Prism 6 (GraphPad Software, La Jolla, CA, USA) using Student's t tests or one-way ANOVA. Differences were considered to be a statistical significance at a P-value of <0.05. (Figure 1B) . Moreover, RT-PCR showed that SNHG20 expression was up-regulated in OSCC sphere cells compared with parental cells ( Figure 1C ). Mammosphere-forming assay showed that the diameter of OSCC spheres was increased with the culture days ( Figure 1D ). RT-PCR showed that the RNA expression levels of SNHG20, ALDH1, Nanog, Oct4 and SOX2 were increased following the culture days ( Figure 1E ). Therefore, results conclude that SNHG20 expression was up-regulated in OSCC tissue samples and stem-like cells, suggesting the potential role of SNHG20 on OSCC stemness.
F I G U R E 2
3.2 | LncRNA SNHG20 knockdown suppressed the
CSC properties and tumorigenesis of OSCC in vitro and in vivo
To investigate the role of SNHG20 on OSCC stemness and tumorigenesis, loss-of-function experiments were performed. LncRNA SNHG20 expression levels were significantly down-regulated in Figure 2C ). Besides, RT-PCR showed that SNHG20 knockdown decreased the ALDH1 mRNA ( Figure 2D ). Western blot assay showed that SNHG20 knockdown decreased the expression levels of stem factors (LIN28, Nanog, Oct4, SOX2) ( Figure 2E ). In xenograft mice in vivo assay, SNHG20 knockdown suppressed the tumour growth of OSCC-CSC (CSC-SCC15), including tumour volume and weight ( Figure 2F ). Taken together, results revealed that SNHG20 knockdown suppressed the CSC properties and tumorigenesis of OSCC in vitro and in vivo.
F I G U R E 4 SNHG20/miR-197/LIN28 axis regulated OSCC proliferation and stemness. A, CCK-8 assay showed the proliferation of CSC-SCC15 cells transfected with si-SNHG20, miR-197 inhibitor and LIN28 siRNA. B, RT-PCR showed the ALDH1 expression. C-E, Sphere formation assays showed the mammosphere-forming ability (sphere diameter, sphere number). F, Western blot analysis showed the stem factors (Nanog, Oct4, SOX2) expression levels in SCC15 cells co-transfected with LIN28 siRNA, si-SNHG20 and miR-197. Data are presented as the mean ± SD. *P < 0.05, **P < 0.01 compared to control group. ns presented the no significance 
| DISCUSSION
Emerging evidences have illustrated the important roles of cancer stem-like cells (CSC) in human tumours, including OSCC. 12, 13 In present study, our team aims to investigate the biological role of SNHG20 on the stemness and tumorigenesis of OSCC.
In the oncogenesis of OSCC, it has been verified that long noncoding RNAs (lncRNAs) participate in a series of pathophysiological process. [14] [15] [16] LncRNA SNHG20 is remarkably up-regulated in multiple tumour tissues compared with adjacent non-tumour tissues, predicting poor prognosis for patients, including hepatocellular carcinoma, colorectal cancer and so on. 17, 18 In this research, our results found that SNHG20 was up-regulated in OSCC tissue compared with adjacent normal tissue. Besides, SNHG20 was enriched in OSCC sphere cells compared with parental cells. Therefore, our data illustrate the poor indicator of SNHG20 for OSCC patients; moreover, it is closely correlated with OSCC cancer stem-like properties.
The cancer stem-like properties always make the tumorigenesis complex and cause the recurrence of residual tumour tissue. 19, 20 Therefore, in consideration of the enrichment of SNHG20 in OSCC sphere, we suppose that SNHG20 regulates the stemness of OSCC to modulate its oncogenesis. Loss-of-function experiments indicated that SNHG20 knockdown inhibited the mammosphereforming, ALDH1 expression, stem factors (LIN28, Nanog, Oct4, SOX2) levels, suggesting the CSC-inhibition of SNHG20 knockdown. Although our results reveal the epigenetics role of SNHG20 on OSCC tumorigenesis and stemness, the specific biological functions should be carried out by functional proteins, instead of noncoding RNA. 23, 24 Therefore, we continue to investigate the underlying mechanism within SNHG20 and OSCC stemness. Bioinformatics tools and luciferase reporter assay reveal and validate that miR-197 functions as a "linker" to connect SNHG20 and LIN28
by complementary binding at 3′-UTR. Validation experiments confirm the associated function of SNHG20/miR-197/LIN28 on OSCC tumorigenesis. The regulatory mechanism is described as competing endogenous RNA (ceRNA) theory. [25] [26] [27] [28] LncRNAs harbour miRNAs and absorb dissociative miRNAs, decreasing the abundance in cells. 29, 30 For instance, lncRNA NR2F1-AS1 promoted ABCC1 expression through endogenous sponging miR-363 to regulate hepatocellular carcinoma HCC oxaliplatin-resistance. 31 In this study, we found that SNHG20 functioned as a "sponge" for miR-197, meanwhile, miR-197 also targeted LIN28, forming a whole regulatory pathway. The ceRNA mechanism is a canonical theory for lncRNA in tumour tumorigenesis. For instance, lncRNA PDIA3P is overexpressed in OSCC and indicates the poor survival rate of OSCC patients, which negatively regulates miR-185-5p by targeting cyclin D2. 32 In summary, our experiments preliminarily investigate the role of lncRNA SNHG20 on the OSCC tumorigenesis. Results reveal the important function of SNHG20/miR-197/LIN28 axis in the oncogenesis and stemness of OSCC, suggesting the vital role of SNHG20 in OSCC.
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